
PCSK9 wrangle opens can of worms for antibody makers
Regeneron and Sanofi's PCSK9 court win could reverberate across the whole monoclonal antibody space.
Regeneron and Sanofi's PCSK9 court win could reverberate across the whole monoclonal antibody space.